RNS Number : 7125N
Pittards PLC
24 January 2023
 

 

FOR IMMEDIATE RELEASE                                                                             24 January 2023

                                                                    

 

Pittards plc

("Pittards", the "Group" or the "Company")

Director Appointment  

 

Pittards plc, the specialist producer of technically advanced leather and luxury leather goods for retailers, manufacturers and distributors, is pleased to announce the appointment of Alan Burgess, as Chief Financial Officer to the Board with immediate effect. Alan has worked as the Director of Finance (non-board) and Company Secretary of Pittards since 28 March 2022.

 

Alan holds a PhD in Management Science, an MBA and is an associate of the Chartered Institute of Management Accountants.  Alan joined Pittards from Tetra Pak CPS UK Ltd and brings a wealth of experience from several industries.

 

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with the appointment of Dr Alan Matthew Burgess, aged 52, to the Board of the Company:

Current directorships/

Partnerships

Past directorships/Partnerships held within the last five years

My Temp FD Ltd

None

 

 

Alan holds 21,643 ordinary shares in the Company (representing 0.16% of the issued share capital of the Company and 0.17% of the Company's total voting rights).

 

There are no other matters under paragraph (g) of Schedule 2 of the AIM Rules to be disclosed.

 

 

Contacts:

Pittards plc

www.pittards.com

Stephen Yapp, Chairman

Reg Hankey, CEO

Alan Burgess, CFO

+44 (0) 1935 474 321

 

WH Ireland Limited

www.whirelandcb.com

Mike Coe, Sarah Mather

+44 (0)20 7220 1666

Walbrook PR

pittards@walbrookpr.com

Paul Vann, Joe Walker

+44 (0)20 7933 8780/ +44 (0)7768 807631


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFELLEISFIV